Search
for
Sort by
Research 30 of 129
- Dermatological Manifestations of COVID-19: A Brief Review
- Erlotinib-related Severe Hair Loss with Severe Exanthematous Drug Eruption: A Case Report
- Etoricoxib
- Cutaneous Drug Reaction Case Reports
- Clinical and Histopathological Features and Potential Pathological Mechanisms of Skin Lesions in COVID-19: Review of the Literature
- Circumferential acute limited exanthematous pustulosis
- Cutaneous drug reactions
- Skin Manifestations in Confirmed COVID 19 Patients; A Short Prospective Multicenter Case Series Cohort Study
- Clinical manifestations of cutaneous lupus erythematosus
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Reactions to Drugs
- Skin
- Cutaneous manifestations of COVID-19
- Acute Localised Exanthematous Pustulosis
- Flagellate Shiitake Mushroom Reaction With Histologic Features of Acute Generalized Exanthematous Pustulosis
- Confirmation of Metformin-Induced Acute Generalized Exanthematous Pustulosis Through a Positive Dechallenge-Rechallenge Test: A Case Report and Review of Cutaneous Manifestations Associated With Metformin
- Cutaneous manifestations of the COVID-19 pandemic in schoolchildren and adolescents
- 567 Acute generalized exanthematous pustulosis (AGEP) induced by plaquenil
- Severe cutaneous adverse reactions to drugs
- COVID-19 infection leading to acute pustular dermatoses
- Acute Localized Exanthematous Pustulosis (ALEP) Caused by Topical Application of Minoxidil
- Semaglutide-Induced Atypical Pustular Drug Eruption: A Case Report
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Nodular-cystic eruption in course of sorafenib administration for hepatocarcinoma: An unconventional skin reaction requiring unconventional treatment
- The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
- Cutaneous lupus erythematosus
- Cirmcumscribed juvenile pityriasis rubra pilaris in a 5-year-old-girl treated with topical keratolytic and steroid
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Trans-Epidermal Elimination Due to Insulin Formulation: Report of a Rare Adverse Effect